RecruitingNot ApplicableNCT06628986

MBSR and NLP, Postpartum Breastfeeding and Depression

the Effect of MBSR and NLP Applications on Fatigue, Sleep Quality, Lactation and Postpartum Depression in the Postpartum Period After Caesarean Section


Sponsor

Aysegul Kilicli

Enrollment

90 participants

Start Date

Oct 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The postnatal period is a risky period in which mothers experience regressive and progressive changes and rapid biopsychosocial changes. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes that occur in this period.


Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether mindfulness-based stress reduction (MBSR) and a technique called neurolinguistic programming (NLP) can help new mothers who had a C-section to breastfeed more successfully and reduce symptoms of postpartum depression. **You may be eligible if...** - You are between 19 and 35 years old - You recently gave birth via caesarean section (C-section) - This is your first baby - You are currently breastfeeding **You may NOT be eligible if...** - You do not wish to participate in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMBSR

20 minutes once a week for 8 weeks

BEHAVIORALNLP

NLP Neurolinguistic programming, 20 minutes once a week for 8 weeks

BEHAVIORALcontrol

control group, no practice,


Locations(1)

Şanlıurfa training and research hospital

Sanliurfa, Eyalet/Yerleşke, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06628986


Related Trials